Co-diagnostics (CODX) Fundamental Analysis: Revenue, Earnings & Valuation

0.49 / 10

Underperform

Fundamental assessment rates CODX as Underperform with a 0.5/10 score. Asset‑MV and Profit‑MV are modestly positive, while Revenue‑MV, Cash‑MV, ROA and profit margins are negative, indicating weak earnings and cash generation. Overall fundamentals are guarded.

Analysis Checks(3/10)

Revenue-MV

Value-0.28

Score0/3

Weight29.23%

1M Return-4.18%

ROA (%)

Value-38.90

Score1/3

Weight6.09%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-6397.03

Score0/3

Weight32.36%

1M Return-6.63%

Profit-MV

Value0.40

Score2/3

Weight-27.61%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-51.87

Score1/3

Weight6.09%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-6227.96

Score0/3

Weight32.37%

1M Return-5.19%

Asset-MV

Value-0.49

Score3/3

Weight-41.93%

1M Return4.62%

Net profit / Total operating revenue (%)

Value-5898.54

Score0/3

Weight32.95%

1M Return-6.68%

Cash-MV

Value-0.09

Score1/3

Weight26.17%

1M Return-4.16%

Net profit / Total profit (%)

Value94.88

Score2/3

Weight4.28%

1M Return-0.54%

Is CODX fundamentally strong?

CODX scores 0.49/10 on fundamentals and holds a Premium valuation at present. Backed by its -44.93% ROE, -7533.62% net margin, -0.14 P/E ratio, 0.17 P/B ratio, and 5.29% earnings growth, these metrics solidify its Underperform investment rating.